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ABSTRACT
Objectives: To evaluate the rates of pain and mass recurrence of the patients over 40 years old with endometriosis who 
underwent ovarian cystectomy or uni/bilateral oophorectomy. 
Material and methods: A retrospective study was conducted with 98 patients undergoing laparoscopic surgery for en-
dometriosis in a tertiary referral center between the time period July 2015 and July 2019. All the patients followed every 
3 months and requested to fill the Visual Analogue Scale (VAS) for evaluation of pelvic pain and an ultrasound scan was 
performed. The inclusion criteria for this study were as follows, patients with ages over 40, with regular menstrual periods, 
and who denied hysterectomy and any postoperative hormonal medical treatments.
Results: When the groups were compared in terms of age, body mass index, cyst diameter, CA-125 serum concentrations, 
preoperative and after surgical pelvic pain scores, mean follow up periods, postoperative hospital stay. However, each of 
the mean numbers of gravidity and parity were significantly higher than bilateral salpingo-oophorectomy (BSO) groups 
compared to the other groups (p = 0.04 and p = 0.03, respectively). The laterality, the recurrence rates, and the type of 
recurrence did not have a significant effect in the group comparison. 
Conclusions: The ovarian tissue preserving procedures could be offered for the women over 40 years old suffering from 
endometriosis with no significant increase in pain symptom or mass recurrence rates considering beneficial effects of 
estrogen on cardiovascular system, vasomotor symptoms, and bone mineral density.
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INTRODUCTION 
Endometriosis is characterized by the existence of 
endometrial-like tissue outside of the uterine cavity and 
especially endometriosis causes pelvic pain and infertility 
during oestrogen-dependent reproductive years. The most 
affected organ is the ovary, and this affected ovarian tissue 
is called a chocolate cyst or ovarian endometrioma. Ovar-
ian endometriomas are observed in 17–44% of women with 
endometriosis [1].
Laparoscopic conservative surgery is recommended as 
the main surgical treatment in ovarian endometrioma [2–3]. 
However, the recurrence of endometrioma after surgery is 
a major problem. The rate of recurrence is very highly vari-
able and reported with a range between 19% and 50% [4]. 
This recurrence may cause the reappearance of pelvic pain 
and requiring repeat surgery. The mechanism of recurrence 
is not fully understood, though it is generally believed to be 
as follows: the lesion is not removed completely, leading to 
recurrence from the residual lesion; eutopic endometrial 
tissue is the key factor in the onset of endometriosis ac-
cording to the known retrograde menstruation theory [5]. 
In addition, there is no general agreement in evaluating the 
conditions that may cause the recurrence of endometrioma. 
The age of the patient at the time of the operation was 
thought to affect the recurrence of endometriosis [6]. Until 
now, there has been a remarkable inadequacy of attention in 
the management opportunities for endometriosis patients 
who are past their reproductive years and in the natural 
transition towards menopause. However, compared with 
younger women, women older than 40 years may have more 
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dilemmas during management, such as whether to retain 
ovarian tissue and whether it is necessary to add medical 
treatment after surgery in those for whom the use of oral 
contraceptives is no longer recommended [7]. Additionally, 
new studies of the factors related to postoperative recur-
rence in women over 40 years of age with endometriosis 
would help to provide references for the surgical strategy.
In conclusion, our study was aimed to determine the 
recurrence conditions after cystectomy or uni/bilateral oo-
phorectomy surgeries for ovarian endometrioma in patients 
aged older than 40 years. 
MATERIAL AND METHODS
All premenopausal women over 40 years of age who 
experienced laparoscopic surgery for endometrioma were 
observed at our tertiary referral centre between January 
2015 and January 2018.
The inclusion criteria were as follows: there was postop-
erative histopathological confirmation, patients had regular 
menstrual periods and denied the hysterectomy procedure 
and postoperative hormonal treatment, clinical follow-up 
and pathological data were completed, and patients were 
classified with stage 3/4 endometriosis patients according 
to the American Society of Reproductive Medicine (ASRM) 
classification [8]. The exclusion criteria were hysterectomy; 
ovarian endometrioma treated with ablation, drainage or in-
completely stripping; postmenopausal status; other types of 
postoperative treatment, such as combined oral contracep-
tives, progestins, gonadotropin-releasing hormone agonists 
(GnRHa) or levonorgestrel-releasing intrauterine devices; 
and a histopathology of malignancy or borderline tumours.
The following data, including age, number of pregnan-
cies, ovarian size (mm), laterality of ovarian cysts, preop-
erative and postoperative 3rd month visual analogue scales 
(VAS), body mass indexes, preoperative CA-125 levels, types 
of laparoscopic surgery, and recurrence during follow up 
(month) were retrospectively evaluated. Women were each 
requested for observation three months of the initial year 
and then annually.
The definition of recurrence of endometrioma was a radi-
ologic appearance of an endometrioma with a circular-form 
cyst structure (at least 2 cm in size), surrounded with thick 
membrane, regularly boarded, and homogenous depleted 
echogenic substance with dispersed internal echogenic 
appearance, the absence of papillary structures, and/or 
pelvic pain [9].
In our study, we performed cystectomy, unilateral 
salpingo-oophorectomy (USO) and bilateral salpingo-oo-
phorectomy (BSO), and the data from these three groups 
of patients were analysed.
The surgery was done throughout an umbilical inser-
tion and right and left infra- umbilical insertions by 5 mm 
grasping forceps and scissors. Pneumoperitoneum was 
obtained using a Veress needle (Ethicon Endo-surgery Inc., 
USA) insertion. In all cases CO2 was used with 12 mmHg 
intrabdominal pressure. An incision was performed on the 
endometrioma, and the tissues were dissected, and then 
exposed. After aspiration of the cyst contents, pathologi-
cal tissue was pulled from different angles and separated 
from ovarian parenchyma. Haemostasis was accomplished 
by bipolar coagulation. Additionally, laparoscopic USO and 
BSO procedures were performed with the same process 
and subsequent infundibulopelvic ligament identification 
and adnexal removal. When the adhesion was observed 
endometrioma were released from normal tissue by dif-
ferent cleavages. After endometriomas were removed vis-
ible endometriotic lesions were excised or coagulated with 
bipolar energy. Anatomical restoration was then achieved 
in all cases.
Data analysis was achieved with SPSS (version 20.0; SPSS 
Inc., Chicago, IL, USA). All data were shown as mean ± stan-
dard deviation. A one-sample Kolmogorov–Smirnov test 
was accomplished to examine the dispersion of clinical and 
surgical outcomes. Parametric variables were analyzed by 
Student’s t-test; non-parametric variables were analyzed 
by Mann–Whitney U test and chi-square test. A p-value 
of < 0.05 was determined to be statistically significant for 
analysis. 
RESULTS 
A total of 98 patients who had an adequate after surgical 
follow-up and met the inclusion criteria were participated 
in the study. The main groups of study were cystectomy 
patients (n = 30), USO patients (n = 39) and BSO patients 
(n = 29). The baseline characteristics are shown in Table 1. 
When the groups were compared, there was no signifi-
cant effect of patient age during the operation. However, 
the mean numbers of both gravidity and parity were sig-
nificantly higher in the BSO group compared to the other 
groups (p = 0.04 and p = 0.03 respectively). There were no 
significant differences between the groups regarding body 
mass index, preoperative CA-125 levels, preoperative and 
postoperative third month VAS scores, the number of pre-
vious endometriosis surgeries, ovarian lesion size or post-
operative hospital stay. The mean postoperative follow-up 
was 23.0 months (range 3–34 months) in all women. There 
were also no significant differences in the recurrence time 
after surgery between the groups.
The risk factors associated with the endometrioma re-
currence are presented in Table 2. There were no differences 
between the groups regarding the laterality of lesions or the 
usage of preoperative medication. Additionally, the pres-
ence of a pouch of Douglas obliteration did not significantly 
affect the recurrence rate. 
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The recurrence rate following endometrioma surgery 
was 13.3% in the cystectomy group, 10.3% in the USO 
group and 6.9% in the BSO group. There were no statisti-
cally significant differences in the recurrence rate between 
the groups. Additionally, a type of recurrence analysis was 
conducted between the cystectomy group (pain 6.7%, mass 
6.7%), USO group (pain 7.7%, mass 2.6%), and BSO group 
(pain 6.9%, mass 0%); and there were no statistically signifi-
cant difference within these groups.
DISCUSSION
This study evaluated the rates of pain and mass recur-
rence in patients over 40 years old with endometriosis 
who underwent ovarian cystectomy or uni/bilateral oo-
phorectomy surgeries. The recurrence rate reported in the 
literature varies significantly from 6% to 67% due to dif-
ferent follow-up durations, different surgical techniques 
and different diagnostic criteria [11–12]. Age-dependent 
endometriosis data have demonstrated that a younger age 
during the endometriosis operation is related with recur-
rence of endometrioma [13–14]. Another study showed 
that endometrioma recurrence was higher in patients un-
dergoing an endometriosis operation under the age of 
32 [15]. In younger women, endometriomas may be more 
aggressive due to a high level of hormones, consequently 
it may cause more recurrence rates [15–16]. Additionally, 
a study showed that endometriosis might develop from 
follicles or the corpus luteum [17]. On the other hand, this 
issue was discussed for the first time in 1993 by Witt and 
Barad with a study proposed at discussing the treatment 
modalities in women with an endometrioma above 40 years 
of age [18].
Table 1. Comparison of the basic characteristics of the study groups
Cystectomy (n: 30) USO (n: 39) BSO (n: 29) p value
Age [years] 41.86 ± 3.27 42.64 ± 3.08 43.34 ± 3.16 0.1
Gravidity 1.36 ± 1.15 1.58 ± 0.71 1.93 ± 1.09a,b,c 0.04
Parity 1.31 ± 1.11 1.55 ± 0.69 1.82 ± 1.1d,e,f 0.03
BMI [kg/m2] 24.14 ± 2.35 25.89 ± 3.57 26.23 ± 4.27 0.07
Size [mm] 70.3 ± 34.83 66.43 ± 26.33 53.85 ± 23.07 0.27
CA-125 IU/mL 85.43 ± 129.32 96.49 ± 181.64 73.36 ± 68.03 0.66
Pre-op Pelvic pain [VAS] 8 (0–10) 8 (0–10) 8 (0–10) 0.99
Post-op 3rd month Pelvic pain [VAS] 3.5 (0–7) 4 (0–8) 3 (0–9) 0.61
Number of previous endometriosis surgeries 0.16 ± 0.46 0.23 ± 0.58 0.13 ± 0.35 0.83
Mean follow-up [months] 24.26 ± 10.49 22.10 ± 10.75 22.51 ± 9.77 0.51
Hospital stay [days] 3.63 ± 1.71 3.23 ± 1.11 3.96 ± 2 0.40
Recurrence time [months] 2.83 ± 7.79 2.61 ± 8.11 0.93 ± 4.47 0.69
A p value of < 0.05 was considered significant for all bold values; USO — unilateral salpingo-oophorectomy; BSO — bilateral salpingo-oophorectomy; VAS — visual 
analogue scale; BMI — body mass index; a, d — p < 0.001 (cystectomy vs USO), b, e — p < 0.001 (cystectomy vs BSO), c, f — p < 0.001 (USO vs BSO)
Table 2. Comparison of the risk factors associated with the endometrioma recurrence of the study groups
Cystectomy USO BSO p value
Laterality
Unilateral 21 (70%) 24 (61.5%) 13 (44.8%)
0.06
Bilateral 9 (30%) 15 (38.5%) 16 (55.2%)
Preoperative
medication
Yes 8 (26.7%) 11 (28.2%) 7 (24.1%)
0.82
No 22 (73.3%) 28 (71.8%) 22 (75.9%)
Douglas obliteration
Yes 22 (73.3%) 28 (71.8%) 18 (62.1%)
0.35
No 8 (26.2%) 11 (28.2%) 11(37.9%)
Recurrence rate
Yes 4 (13.3%) 4 (10.3%) 2 (6.9%)
0.41
No 26 (86.7%) 35 (89.7%) 27 (93.1%)
Type of recurrence
Pain 2(6.7%) 3(7.7%) 2(6.9%)
0.58Mass 2 (6.7%) 1(2.6%) 0
None 26 (86.7%) 35 (89.7%) 27 (93.1%)
USO — unilateral salpingo-oophorectomy; BSO — bilateral salpingo-oophorectomy; a  p value of < 0.05 was considered significant for all bold values
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Oestrogen plays important roles in processes that 
protect heart and bone physiology [19]. Along with these 
significant effects of oestrogen, the physical changes dur-
ing the perimenopausal years are established in hormonal 
alterations, particularly variations in the level of circulating 
oestrogen. This premenopausal population faces extraordi-
nary problems while managing the effects of endometriosis 
on the patient. Some of these comprehended the elevated 
risk of medical contraindications to combined hormonal 
contraceptives (COC) and prolonged disease significantly 
increases the risk of cancer, with the possibility of causing 
malignant transformation [20]. Because of this condition, 
and considering the different types of laparoscopic surger-
ies, the management of oestrogen-dependent diseases 
such as endometriosis may become complicated in women 
over 40 years old due to the severe alterations of oestrogen 
levels. According to these data, our study is focused on 
determining the rate of recurrence in patients over 40 years 
old with endometriosis who underwent different type of 
laparoscopic surgeries.
Variations in recommended recurrence criteria, fol-
low-up time, and study populations may result in different 
rates of recurrence rates of endometrioma in the literature 
[21]. Chan et al. [22] founded that dysmenorrhea and sep-
tated ovarian cysts significantly altered the recurrence rate 
after surgery. Additionally, a study showed that the depth 
of invasion of the endometrial tissue into the normal tissue 
was an independent risk factor for recurrence rate of endo-
metrioma [23]. Another study showed that CA-125 serum 
concentrations, cyst diameter and previous pelvic surgery 
would affect the recurrence rate [24]. Our study showed 
no significant association between recurrence rate and 
patient-related factors such as gravidity, parity, preopera-
tive serum CA-125 level, body mass index and cyst diameter. 
Additionally, Campo et al. [25] investigated that the relation-
ship between endometrioma recurrence and surgical situ-
ations such as mass size, number and laterality, adhesions 
or implantations, existence of spillage and demographic 
situations such as age, body mass index, family history; the 
authors showed that family history of endometriosis was the 
only factor affecting endometrioma recurrence rate. On the 
other hand, another study suggested that the cumulative 
recurrence rate of ovarian endometrioma was related with 
the since onset of time follow-up and severe endometriosis, 
as the second-line surgery seemed to be a risk factor as-
sociated with the increased recurrence rate [26]. Previous 
studies concluded that the cumulative recurrence rates 
of conservative surgery, semi-radical surgery and radical 
surgery were 28.9%, 17.3% and 0% respectively [27]. In our 
study, the cumulative recurrence rates in the cystectomy, 
USO and BSO surgery group were 13.3%, 10.3% and 6.9%, 
respectively. 
The international guidelines on endometrioma have 
not recommended exact suggestions for the management 
of patient approaching menopause, likely due to the lack 
of evidence. The 2014 European Society of Human Repro-
duction and Embryology guidelines suggest considering 
definitive operation (hysterectomy with bilateral oophorec-
tomy, together with the removal of other lesions) for women 
who terminate their reproductive life and had persisting 
symptoms despite medical therapy [28]. The guidelines 
also proposed to brief the women in whom hysterectomy 
would not necessarily treat endometriosis symptoms. Alike 
recommendations have been suggested by the Society of 
Obstetricians and Gynecology of Canada [29]. In addition, 
the World Endometriosis Society consensus on the present 
treatment of endometriosis has announced that sugges-
tions were associated to women of reproductive age but 
emphasized that the role of hysterectomy and simultaneous 
oophorectomy demonstrates the ensuring a little reliable 
evidence effect [30]. On the other hand, in recent years, 
an increasing number of patients have expected to preserve 
the ovaries and the uterus. All patients included in our study 
denied hysterectomy procedure. Additionally, clinicians pay 
more attention to the preservation of reproductive organs 
in perimenopausal patients due to the beneficial effects of 
oestrogen levels. Furthermore, additional operations may 
increase the duration of surgery and morbidity. Zing et al. [7] 
showed that the ovarian preservation surgery was an in-
dependent risk factor for recurrence in patients with ovar-
ian endometriosis (> 45 year old). However, our results 
showed no significant difference in recurrence rate with 
different types of endometrioma surgeries. 
In different studies evaluating the pathophysiology of 
recurrence, it has been suggested that the recurrent lesion 
may derived from remaining tissue. Failure to completely 
remove pathological tissues at the time of primary surgery 
may increase the likelihood of recurrence to endometrioma, 
and the larger part of recurrent lesions were formed in 
the same area [31–32]. Thus, during the primary surgery 
for endometriosis, an excellent surgical technique and the 
experienced endometrioma surgeons are critical due to the 
capability of pathologic residual tissue to grow.
For many years, the medications used in the man-
agement of endometriosis included selective oestrogen 
receptor modulators, aromatase inhibitors, GnRHa, selec-
tive progesterone receptor modulators and angiogenic 
agents. A Cochrane review on the use of postoperative 
medication in endometriosis suggested that there was no 
evidence of any improved pain relief, though the level of 
evidence was not sufficient in the reported literature [5]. 
However, A study found that use of GnRHa after surgery 
could only extend the recurrence interval but not decrease 
the whole recurrence rate [33]. In our study, endometrioma 
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management included only surgery without the addition 
of postoperative medications. 
However, our study also has a few limitations. First the 
study was not a randomized controlled study; therefore, 
some possible biases could have occurred. In addition, our 
study focused on different types of adnexal surgeries, and 
hysterectomy operations could be added for the analy-
sis. Additionally, patients with histopathology of malignancy 
or borderline tumours were excluded from the study due 
to the requirement of oncologic management. This situa-
tion may cause additional limitation in our study. Although 
endometriosis-associated malignant ovarian tumours are 
usually early stage, oncologic safety of the surgical pro-
cedures such as cystectomy could not be analyzed due to 
this limitation [34]. Finally, this study had a relatively small 
sample size. 
In conclusion, the rate and prevention of disease recur-
rence in women approaching menopause are unknown 
factors. Our study showed that ovarian tissue-preserving 
procedures could be offered for the women over 40 years 
old suffering from endometriosis with no significant increase 
in pain symptoms or mass recurrence rates considering the 
beneficial effect of oestrogen on the cardiovascular system, 
vasomotor symptoms and bone mineral density. 
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